Lanean...
The clinical potential of romosozumab for the prevention of fractures in postmenopausal women with osteoporosis
The glycoprotein sclerostin inhibits activation of the canonical Wnt pathway and thereby suppresses bone formation by inhibiting the osteoblasts. Additionally, sclerostin increases bone resorption by stimulating the production of receptor activator of nuclear factor kappa-β-ligand (RANKL). Romosozum...
Gorde:
| Argitaratua izan da: | Ther Adv Musculoskelet Dis |
|---|---|
| Egile Nagusiak: | , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
SAGE Publications
2018
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6009094/ https://ncbi.nlm.nih.gov/pubmed/29942362 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1759720X18775936 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|